1548 related articles for article (PubMed ID: 10592406)
1. The use of itraconazole to treat cutaneous fungal infections in children.
Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
[TBL] [Abstract][Full Text] [Related]
2. Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview.
Doncker PD; Gupta AK; Marynissen G; Stoffels P; Heremans A
J Am Acad Dermatol; 1997 Dec; 37(6):969-74. PubMed ID: 9418766
[TBL] [Abstract][Full Text] [Related]
3. Update in antifungal therapy of dermatophytosis.
Gupta AK; Cooper EA
Mycopathologia; 2008; 166(5-6):353-67. PubMed ID: 18478357
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Gupta AK; Gregurek-Novak T
Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
[TBL] [Abstract][Full Text] [Related]
5. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole.
Möhrenschlager M; Schnopp C; Fesq H; Strom K; Beham A; Mempel M; Thomsen S; Brockow K; Wessner DB; Heidelberger A; Ruhdorfer S; Weigl L; Seidl HP; Ring J; Abeck D
Br J Dermatol; 2000 Nov; 143(5):1011-5. PubMed ID: 11069511
[TBL] [Abstract][Full Text] [Related]
6. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
7. Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis.
Gupta AK; Ginter G
Pediatr Dermatol; 2001; 18(6):519-22. PubMed ID: 11841643
[TBL] [Abstract][Full Text] [Related]
8. Systemic antifungal therapy for tinea capitis in children.
Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
[TBL] [Abstract][Full Text] [Related]
9. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
[TBL] [Abstract][Full Text] [Related]
11. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.
Tosti A; Piraccini BM; Stinchi C; Colombo MD
Dermatology; 1998; 197(2):162-6. PubMed ID: 9732167
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
[TBL] [Abstract][Full Text] [Related]
13. Treatment of tinea capitis with itraconazole capsule pulse therapy.
Gupta AK; Hofstader SL; Summerbell RC; Solomon R; Adam P; Alexis M; Raboobee N; De Doncker P
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):216-9. PubMed ID: 9704832
[TBL] [Abstract][Full Text] [Related]
14. Common tinea infections in children.
Andrews MD; Burns M
Am Fam Physician; 2008 May; 77(10):1415-20. PubMed ID: 18533375
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the efficacy of oral fluconazole, 150 mg/week versus 50 mg/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis.
Nozickova M; Koudelkova V; Kulikova Z; Malina L; Urbanowski S; Silny W
Int J Dermatol; 1998 Sep; 37(9):703-5. PubMed ID: 9762826
[No Abstract] [Full Text] [Related]
16. The changing face of Microsporum spp infections.
Skerlev M; Miklić P
Clin Dermatol; 2010 Mar; 28(2):146-50. PubMed ID: 20347656
[TBL] [Abstract][Full Text] [Related]
17. Fungus isolated from dermatomycoses: a 9-month prospective study at Hospital Melaka.
Ng LC; Lee CS; Lim BB; Mohd Tap R; Tan XT; Tang MM
Med J Malaysia; 2023 May; 78(3):364-371. PubMed ID: 37271847
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of itraconazole pulse therapy: Brazilian multicentric study on toenail onychomycosis caused by dermatophytes.
Ramos-e-Silva M; Marques SA; Gontijo B; Zaitz C; Campbell I; Veloso ST
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):109-16. PubMed ID: 9784035
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Itraconazole Oral Solution Continuous Therapy for Infantile Tinea Capitis.
Zhou YB; Chao JJ; Ma L; Xiao YY
Am J Trop Med Hyg; 2024 May; 110(5):965-967. PubMed ID: 38531098
[TBL] [Abstract][Full Text] [Related]
20. A U.S. epidemiologic survey of superficial fungal diseases.
Kemna ME; Elewski BE
J Am Acad Dermatol; 1996 Oct; 35(4):539-42. PubMed ID: 8859279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
